Xenios AG
Develops medical devices for lung and heart treatments.
Launch date
Employees
Company register number HRB 743620 (Stuttgart)
Heilbronn Baden-Württemberg (HQ)
Financials
Estimates*
EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|---|
Revenues | 1.9m | - | - | - | - | - | - |
EBITDA | (1.7m) | (13.0m) | (3.7m) | (8.4m) | (36.3m) | (23.4m) | (22.7m) |
% EBITDA margin | (89 %) | - | - | - | - | - | - |
Profit | (2.4m) | (14.9m) | (4.7m) | (11.5m) | (39.9m) | (2.5m) | (7.3m) |
% profit margin | (125 %) | - | - | - | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Seed | ||
N/A | Acquisition | ||
Total Funding | - |
Related Content
Recent News about Xenios AG
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Xenios AG
EditACQUISITION by Xenios AG Jun 2013